Studies related to Prostate Cancer Risk and Curcumin

Combined Inhibitory Effects Of Soy Isoflavones And Curcumin On The Production Of Prostate-specific Antigen

Effect Decrease
Trial Design Double blind
Trial Length n/a
Number of Subjects 85
Sex n/a
Notes for this study:
Prostate cancer risk as assessed by Prostate Specific Antigen (PSA); a combination of soy isoflavones (40mg) and curcumin (100mg) was synergistically active (as assessed in vitro) in reducing circulating levels of prostate specific antigen in a population of non-cancerous, elderly japanese men (median age 73)

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.